GL1X · GenesisL1 explorer

Research workbench

Human PFKFB3 in complex with an indole inhibitor 5

Analyse Human PFKFB3 in complex with an indole inhibitor 5 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5AJZ
Type
protein
Length
440 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
6-phosphofructo-2-KINASE/FRUCTOSE-2,6-bisphosphatase 3
EC
2.7.1.105, 3.1.3.46
UniProt
Q16875
Ligands
PHS, F6P, MJP, PO4
Pockets
3 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A6-phosphofructo-2-KINASE/FRUCTOSE-2,6-bisphosphatase 3 (EC 2.7.1.105, 3.1.3.46)protein44043% helix, 17% strandQ16875

Ligands and binding sites

  • PHS · Phosphonic acid · ligand · chains A
  • F6P · 6-O-phosphono-beta-D-fructofuranose · ligand · chains A
  • MJP · 2-azanyl-N-[4-[(3-cyano-1H-indol-5-yl)oxy]phenyl]ethanamide · ligand · chains A
  • PO4 · Phosphate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13500.780.8943PO4
21700.720.9037PHS, F6P
33160.700.8340MJP

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5AJZ · Human PFKFB3 in complex with an indole inhibitor 5 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q16875 · AlphaFold monomer V2.0 prediction for 6-phosphofructo-2-KINASE/FRUCTOSE-2,6-bisphosphatase… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.